SCHEMBL334275

SCHEMBL334275

CC(=O)OCCc1ccc(C)c(O)c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
APP P05067 4/20 0.51
YWHAG P61981 1/20 0.51
TYR P14679 2/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
PTGS1 P23219 1/20 0.41
BLM P54132 1/20 0.41
HIF1A Q16665 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MET P08581 4/20 0.41
ALOX5 P09917 1/20 0.40
TNKS2 Q9H2K2 1/20 0.39
RAD52 P43351 1/20 0.39
IAPP P10997 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30306725 0.86 APP (0.68) APPYWHAGKDM4EALDH1A1LMNA
SCHEMBL12117745 0.86 CNR1 (0.44) APPYWHAGALDH1A1MAPTHPGD
SCHEMBL5613913 0.86 APP (0.68) APPYWHAGKDM4EALDH1A1LMNA
SCHEMBL8524340 0.83 CYP3A4 (0.53) KDM4EALDH1A1HSD17B10
SCHEMBL11556451 0.82 APP (0.50) APPYWHAGTYRKDM4EALDH1A1
SCHEMBL27625901 0.82 APP (0.50) APPYWHAGTYRKDM4EALDH1A1
SCHEMBL27652713 0.82 APP (0.50) APPYWHAGTYRKDM4EALDH1A1
SCHEMBL17253828 0.82 APP (0.50) APPYWHAGLMNAPTGS1MET
SCHEMBL12117363 0.81 TNKS2 (0.50) APPALDH1A1LMNAMETALOX5
SCHEMBL22228089 0.79 APP (0.50) APPYWHAGTYRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122028974-A Ribonucleic acid-based microcapsules 弗门尼舍有限公司 2026-05-12 CN disclosed
CN-120091807-A Lipid-based microcapsules 弗门尼舍有限公司 2025-06-03 CN disclosed
CN-120076721-A Wax-based microcapsules 弗门尼舍有限公司 2025-05-30 CN disclosed
US-8097610-B2 Derivative having PPAR agonistic activity SHIONOGI & CO., LTD. (JP) 2012-01-17 US disclosed
US-20090286974-A1 Derivative having ppar agonistic activity SHIONOGI & CO., LTD. (JP) 2009-11-19 US disclosed
EP-1939189-A1 DERIVATIVE HAVING PPAR AGONISTIC ACTIVITY SHIONOGI & CO., LTD. (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286974-A1 Derivative having ppar agonistic activity PPARD, PPARA, PPARG APP 4058/4885YWHAG 1747/4885TYR 2289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.